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Abstract: Purpose: Unplanned resection of musculoskeletal sarcoma involves tumor excision without any suspicion of 
malignancy or regard for the necessity of defining adequate margins. For orthopaedic oncologists, many opportunities 
arise for management of unplanned resections initially performed by non-specialist surgeons. The puropose of this study 
is to assess the clinical outcomes and the problems of the patients with unplanned resection of high-grade soft tissue sar-
coma. 
Methods: 77 consecutive patients were retrospectively reviewed. Oncological outcomes together with validity and prob-
lems of additional treatments were analyzed. 
Results: Five-year local recurrence-free survival, metastasis-free survival, event-free survival and total survival were 
71.55%, 73.2%, 57.5% and 85.9%, respectively. Among adjuvant therapy including additional wide resection, radiother-
apy and systemic chemotherapy, only additional wide resection significantly improved oncological outcomes. 
Conclusion: Additional wide resection appears to be effective in the treatment of high-grade soft tissue sarcomas follow-
ing primary resection with compromised margins of resection. 
INTRODUCTION 
  Unplanned resection of soft tissue sarcoma is defined as 
excision without regards for the necessity to remove a mar-
gin of normal tissue covering the tumor without histological 
diagnosis by biopsy [1-3]. Although the principle of treat-
ment for high-grade soft tissue sarcoma has been established 
as preoperative histological evaluation by biopsy and exci-
sion with adequate margin [4, 5], numerous chances still 
remain in specialist cancer institutes to manage soft tissue 
sarcoma cases following unplanned resection initially per-
formed by non-specialist orthopaedic surgeons, general sur-
geons, plastic surgeons or dermatologists. The purpose of 
this study was to assess the following in patients with un-
planned high-grade soft tissue sarcoma referred from non-
specialists surgeons: 1) oncological outcomes; 2) validity of 
additional treatments; and 3) profile and problems of addi-
tional wide resection. 
MATERIALS AND METHODS 
  Subjects comprised 77 patients (39 men, 38 women; 
mean age, 49.3 years) who had initially undergone un-
planned resection of high-grade soft tissue sarcoma by non-
specialist surgeons and had been referred to our hospital be-
cause of histological diagnosis of high grade sarcoma over 
the past three decades. Patients with metastases at presenta-
tion were excluded, as were patients referred more than two 
months after initial unplanned resection. In addition, even 
though the surgery was performed immediately, patients   
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with obvious palpable masses considered as macroscopic 
residual tumor due to incomplete resection rather than local 
recurrence were omitted. Finally, patients with low-grade 
cases were excluded from the present study due to the ac-
ceptable oncological outcomes and current controversy re-
garding marginal resection for this condition [6, 7]. 
  Tumors were located in the lower extremity in 40 cases, 
in the upper extremity in 18 and in the trunk in 19. Mean 
duration of follow-up was 75 months (range, 12-240 
months). Histological diagnoses were pleomorphic 
MFH/undifferentiated high grade pleomorphic sarcoma in 24 
cases, synovial sarcoma in 18, malignant peripheral nerve 
sheath tumor in seven, leiomyosarcoma in seven, liposar-
coma in seven and other high grade sarcoma in 14. 
  For 32 cases, non-surgical therapy alone was performed. 
Additional wide resection was performed for the remaining 
45 cases. Among these, 27 cases received neither systemic 
chemotherapy nor radiotherapy. Chemotherapy, radiotherapy 
and combined chemo- and radiotherapy were performed for 
the remaining seven, six and five cases, respectively. 
  Establishment of the concept of safety margin [5] and the 
widespread adoption of magnetic resonance imaging (MRI) 
have resulted in modifications of the treatment policy for 
unplanned resection and the introduction of additional wide 
resection instead of radiotherapy in 1989 in our institute; 
therefore, a negative correlation between the indications for 
additional wide resection and radiotherapy was found in the 
present study. Thus, although no prospectively selected crite-
ria were used for radiotherapy, this adjuvant therapy was 
indicated mainly for cases before 1989. This modality was 
also indicated for patients who declined additional wide re-
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resection cases was indicated by the operating surgeons 
when a higher risk of recurrence was considered to exist on 
clinical grounds. Median total radiation dose was 40 Gy 
(range 20-55 Gy). 
  To determine margins for additional wide resection, 
presence of residual tumor, hemorrhage, edema or scar tissue 
was evaluated using magnetic resonance imaging (MRI) at 
presentation. If available, results of MRI for the lesion be-
fore unplanned resection were carefully inspected. T2-
weighted MRI was useful in evaluation of secondary 
changes within muscle. Enhanced T1-weighted MRI facili-
tated the detection of scar tissue and residual tumor in subcu-
taneous tissue [8]. Hemorrhage, edema or scar tissue were 
thought to be contaminated with tumor and excised with 
adequate margin. For invasive subtypes such as undifferenti-
ated high grade pleomorphic sarcoma or epithelioid sarcoma, 
curative margin was determined. For most other cases, resec-
tion with adequate wide margin was planned. Skin incision 
of the unplanned resection was excised with skin cuffs. De-
tection by residual tumor and determination of the margin in 
the additional wide resection specimen were performed ac-
cording to the standard pathological examination as previ-
ously reported [3-5, 8]. 
  Although recent meta-analyses have suggested some ef-
fect of chemotherapy on total survival, application of chemo-
therapy for high-grade soft tissue sarcoma remains contro-
versial with the exception of round cell tumors [9-11]. If the 
patient accepted the proposed chemotherapy after the disclo-
sure of controversial aspects, systemic chemotherapy was 
performed in the present study. Doxorubicin (60mg/m
2/cyc-
le) and ifosfamide (10g/m
2/cycle) based regimens were used. 
  For these cases, oncological outcomes and validity of 
additional therapy were analyzed. Moreover, in order to ex-
tract the problems with additional wide resection, patients’ 
profiles, complications and validity of other adjuvant therapy 
combined with additional wide resection were also analyzed. 
Oncological outcomes were calculated using the Kaplan-
Meier method [12]. The significance of differences between 
survival curves of populations was evaluated using log-rank 
testing for univariate influence and Cox stepwise regression 
for multivariate influence [13]. Values of p < 0.05 were con-
sidered statistically significant. The start point of the survival 
analysis was the date of first additional treatment. Endpoints 
were local recurrence, metastasis, event-free survival and 
total survival. Independent variables in the present study 
included age, sex, location, size, site, depth, pathology 
(round cell vs non-round cell), additional wide resection, 
radiotherapy and systemic chemotherapy. 
RESULTS 
  Five-year local recurrence-free survival, metastasis-free 
survival, event-free survival and total survival rates were 
71.5%, 73.2%, 57.5% and 85.9%, respectively. Among the 
independent variables tested in this study, only application of 
additional wide resection was conducted to determine predic-
tive values for local recurrence, metastasis, event-free sur-
vival and total survival (Fig. 1, Table 1). 
  In the 45 cases with additional wide resection, five-year 
local recurrence-free survival, metastasis-free survival, 
event-free survival and total survival rates were 87.9%,   
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Fig. (1). Kaplan-Meier estimates of oncological outcomes. Prog-
nostic impact by additional wide resection on local control (A), 
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83.8%, 76.3% and 92.1%, respectively. Inspection of the 
specimen from additional wide resection revealed the resid-
ual tumor in 22 cases (44.8%). Surgical margin was negative 
in 40 cases and positive in five. Plastic surgery was needed 
for soft tissue reconstruction after additional wide resection 
in 23 cases (51.1%). Combined nerve and artery resection 
was needed in seven cases and one case, respectively. Com-
plications were infection in four cases, peroneal nerve palsy 
in two cases and compartment syndrome in one case. Re-
garding oncological outcomes of this subgroup, application 
of radiotherapy or systemic chemotherapy, residual tumor in 
the specimen, plastic surgery and margin of the additional 
wide resection did not represent significant prognostic fac-
tors. The validity of radiotherapy and chemotherapy in addi-
tional wide resection was thus not confirmed. 
DISCUSSION 
  The treatment of choice for cases of unplanned resection 
includes additional wide resection with or without radiother-
apy for local control [14]. Additional wide resection has 
shown outstanding oncological outcomes in previous reports. 
For example, Zoling et al. reported 61 of 67 cases (91%) 
were alive after additional wide resection for inadequate 
margins [15]. Sugiura et al. and Masono et al. reported the 
total five-year survival rates of cases with additional wide 
resection as 84% and 91.3%, respectively [8, 16]. In terms of 
oncological outcomes, the current findings are in accordance 
with those previous data. The criticism has been made that 
the oncological outcomes for additional wide resection might 
include possible bias by smaller mass size, superficial loca-
tion and lower grade in unplanned resection cases [8]. 
Moreover, patients with high-risk tumors might be referred 
before any treatment and will therefore undergo proper re-
section [17]. In the present study, sampling bias by grade 
was avoided by exclusion of low-grade cases. Outcomes 
were, however, as good as those for cases with proper con-
ventional procedure. Although not covering samples in the 
trunk, Lewis et al. showed an interesting data that after ad-
justing for size, depth or grade between the definitive radical 
resection group and additional wide resection group fol-
lowed by unplanned resection, additional wide resection rep-
resented an independent favorable variable [17]. They failed 
to provide clear explanations for this unexpected finding. 
Speculations included the broader margins from additional 
wide resection compared to definitive wide resection, the 
inhibitory effects on the micro-metastases by activating anti-
angiogenic factors secreted by the primary lesion, and activa-
tion of the endogenous immune systems by residual tumor 
cells. 
  The rate of the residual tumor in additional wide resec-
tion specimens reportedly ranges from 40.4% to 57.9% 
[2,8,15,16]. A lack of radiological evidences of residual tu-
mor in most specimens from additional wide resection has 
been emphasized [16]. These issues support the immediate 
application of additional wide resection to cases of un-
planned resection. The impact of residual tumor on on-
cological outcomes remains controversial. Residual tumor 
has been reported as a risk for local recurrence [2] and dis-
ease free survival [8]. Conversely, data from Masono [16] 
and the current study failed to show that the residual tumor 
was an independent risk factor for local recurrence or total 
survival. Candidate biases for this discrepancy include: dif-
ferences among the institutions in the quality and methods of 
the histological examination; differences in the independent 
variables such as histology or grade; differences in the adju-
vant therapies; and differences in the quality of the addi-
tional wide resection procedure. 
  Additional wide resection requires a broader margin than 
in conventional wide resection. This may lead to the need for 
soft tissue reconstruction, prolonged operation time, compli-
cations and functional loss. Rates of wound complication as 
high as 24% and rates of re-operation chance as high as 18% 
have been reported [16]. Difficulties in determining margins 
after unplanned resection have also been noted [8]. The pre-
sent study showed considerable high rate of combined nerve 
resection. All these issues suggested the need for reduction 
in the chance of additional wide resection for unplanned re-
section cases by application of proper conventional wide 
resection as initial treatment for high-grade soft tissue sar-
comas. Thus management principles of soft tissue tumor 
must be widespread among the whole physicians providing 
primary treatments for the disease. 




Multivariate Analysis  
Endpoints  
Significant Predictable 
Variables in Univariate 
Analysis  
  Survival 
Number  
Five Year  
Survival Rate  
p Value  Risk Ratio (exp)  Range  p Value 
Local recurrence  Additional wide resection  (+)  39/45  87.9% 0.0007  4.4 1.7-11.2  0.002 
      (-)  16/32  49.9%             
Metastasis  Additional wide resection  (+)  35/45 83.8%  0.03  2.4  1.1-5.3  0.03 
      (-)  16/32  60.0%             
Events  Additional wide resection  (+)  32/45 76.3%  0.0003  3.2  1.6-6.3  0.0007 
      (-)  8/32  34.1%             
Total survival  Additional wide resection  (+)  42/45  92.1% 0.0002  4.7 1.2-17.8  0.02 
      (-)  19/32  78.3%             
   Radiotherapy  (+)  22/33 75.6%  0.04  0.62  0.2-1.9  0.41 
      (-)  39/44  94.1%           Unplanned Resection of Soft Tissue Sarcoma  The Open Orthopaedics Journal, 2008, Volume 2    129 
  In the current study, cases with radiotherapy showed a 
tendency toward worse oncological outcomes. As the treat-
ment policy was changed in 1989 in our institute, as men-
tioned above, the negative correlation between indications 
for additional wide resection and for radiotherapy was 
marked. Moreover, the dose in the present study was under 
50Gy most cases. Radiation dose for successful control of 
the soft tissue sarcoma with positive margins or unplanned 
resection is reported as over 65 Gy [14,18,19]. We thus ac-
knowledge bias in this retrospective study as to the efficacy 
of radiotherapy. 
  We failed to confirm the functional outcome of un-
planned resection cases due to the lack of the data in early 
cases. Although functional loss following additional wide 
resection might be plausible, no significant evidence has 
been reported. Mean total function using Enneking’s system 
[20] has been reported as ranged from 83.3% to 94.7% [8, 
16], suggesting acceptable function. Despite a trend toward a 
poorer functional outcome in the presence of infection, there 
was no significant factor that leads poorer function [16]. 
These data supported the application of additional wide re-
section in terms of functional results. 
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